# Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma

> **NCT05478473** · NA · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 43 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** Chidamide combined with Toripalimab

## Key facts

- **NCT ID:** NCT05478473
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-27
- **Primary completion:** 2023-08
- **Final completion:** 2024-08
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2023-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05478473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05478473, "Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05478473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*